XORTX Announces Completion of Screening and Enrollment in Bridging Pharmacokinetics Study
XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]
XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial […]
Company Continues to Build Through Channel Program, Sees Growth in 2023
[…]
Ottawa, Ontario–(Newsfile Corp. – November 22, 2022) – C-COM Satellite Systems Inc., (TSXV: CMI) (OTCQB: CYSNF) a leading global provider of commercial grade mobile auto-deploying satellite antenna systems, announced today that it will open a new R&D […]
Dr. Evans brings extensive strategic experience to advance search for XRx-008 Phase 3 development and commercialization partner […]
ANN ARBOR, MI / ACCESSWIRE / November 14, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for […]
VANCOUVER, BC, Nov. 8, 2022 /CNW/ – Scottie Resources Corp. (“Scottie” or the “Company“) (TSXV: SCOT) (OTCQB: SCTSF) (FSE: SR8) is pleased to report new assays on its Blueberry Contact Zone including an intercept of 20.3 g/t gold […]
Vancouver, British Columbia–(Newsfile Corp. – November 7, 2022) – Midnight Sun Mining Corp. (TSXV: MMA) (OTCQB: MDNGF) (the “Company” or “Midnight Sun”) is pleased to release the initial results from drilling conducted on its Solwezi […]
IRVINE, CA / ACCESSWIRE / November 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 first quarter ended September 30, 2022. The Company also filed its Quarterly Report on Form 10-Q […]
CALGARY, Alberta, Nov. 03, 2022 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to […]
Public Safety Innovator Continues Market Expansion Across Multiple Verticals […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com